FDA Again Warns on Balloon Angioplasty for Neurologic Disorders Says transvascular autonomic modulation is off-label and dangerous Mar 08, 2017
FDA Okays Marathon's Emflaza for DMD Corticosteroids already commonly used to treat the condition Feb 09, 2017
FDA Warns on MRI in Patients with Implantable Pumps Medication, mechanical issues may follow exposure Jan 11, 2017
Eteplirsen Approval Seen as Marking New Direction at FDA Decision on rare-disease drug sparked major controversy Dec 28, 2016
Knee Cartilage Repair Product Wins FDA Nod First of its kind to be approved, agency says Dec 13, 2016
Lowering the Bar: How PMDD Went from an Idea to a Diagnosis Sometimes the drug comes first Nov 16, 2016
TCT: For Heart Devices, Will Lag Moving from Europe to U.S. Wane? FDA Commissioner and E.U. representative talk change Nov 02, 2016
FDA Warns of Testosterone Abuse Adverse events tied to abuse include heart attack, heart failure, and stroke Oct 25, 2016
FDA Warns on Cardiac Surgery Heater-Cooler Device Cites mycobacterial contamination risk Oct 13, 2016
AAFP Blinks on Single-Payer and DTC Drug Ads AAFP delegates stopped short of making new policy on single-payer and a ban on DTC ads Sep 20, 2016
Lowering the Bar: Love Potion Number 9 Million? Is the history of "low T" and "hypoactive sexual desire disorder" a tale of profit trumping science? Jul 06, 2016
New Trial 'Justifies' FDA Nod for Ibrance Phase III study had almost identical results as pivotal trial Jun 08, 2016
FDA Warns of Heart Risk with Imodium Permanent and fatal arrhythmias tied to misuse of loperamide Jun 07, 2016
Unapproved Wound Care Products Flood the Market Expert: Closer regulation could prevent many amputations Jun 01, 2016
ADHD: How Did It Leap from Classroom to Boardroom? Adults are now routinely diagnosed with ADHD. Why is that? This Lowering the Bar; Medicine in 21st Century report seeks answers May 22, 2016
Gluttony -- Once a Deadly Sin, Now a Treatable Disorder This "Lowering the Bar: Medicine in the 21st Century" MedPageToday/Milwaukee Journal Sentinel report takes a hard look at binge-eating disorder May 22, 2016
Smartphone App May Help Monitor Depression Patients were amenable to data monitoring by docs May 15, 2016
How to Avoid Misdiagnosis How a patient makes you feel may affect your diagnostic acumen May 13, 2016
FDA: Avoid Cipro, Similar Drugs for Common Infections Agency says risks outweigh benefits May 12, 2016
FDA Warns of Skin Reaction With Olanzapine Zyprexa and Symbyax among products to get warning label May 10, 2016
FDA Warning: Abilify Tied to Impulse Control Problems In rare cases, may prompt "uncontrollable urges" May 03, 2016
Saxagliptin, Alogliptin Linked to Heart Failure, FDA Warns Decision comes 1 year after FDA advisory committee vote Apr 05, 2016
FDA Lifts Restriction On Rosiglitazone Agency sees no need for restrictions after easing them 2 years ago Dec 16, 2015
Slippery Slope: A Targeted Therapy That Misses the Mark? Afinitor racks up FDA approvals, but where is the evidence? Dec 13, 2015
FDA Advisory Panel Unmoved by Gepirone Data Recommends against novel antidepressant; FDA's fairness questioned Dec 02, 2015
Evidence Lacking for Some Fluoroquinolone Use FDA panel says risk-benefit data don't support current labeling Nov 06, 2015
FDA Presses Pause on Novel Testosterone Product Gives FDA chance to "back away from the circus," says sponsor's CEO Nov 02, 2015
Is SAMHSA to Blame for a Broken Mental Health System? Two members of Congress differ on how to fix a failing system Oct 09, 2015
'Too Toxic' Colorectal Cancer Drug Now OK'd FDA approves tipiracil-trifluridine combo, to be sold as Lonsurf Sep 22, 2015
Some Yohimbe Supplements Stronger than Labeled Pharmaceutical-grade yohimbine, used for sexual dysfunction, is passing for a botanical supplement Sep 22, 2015
FDA Approves First PCSK9 Inhibitor Indication given for heterozygous HF and secondary prevention Jul 24, 2015
FDA Approves Drug for Basal Cell Carcinoma Sonidegib becomes second hedgehog inhibitor for locally advanced disease. Jul 24, 2015
Purdue Pulls New OxyContin Application, and Questions Follow FDA disavows previous requirement for study of abuse-deterrent formulation Jul 02, 2015
Evolocumab Receives Mixed FDA Review FDA sees strong efficacy of new injectable heart drug, but questions appropriateness of study population Jun 08, 2015
